{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:39:24Z","timestamp":1758818364160,"version":"3.37.3"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2020-ER6901-02","2023-ER0505-00"],"award-info":[{"award-number":["2020-ER6901-02","2023-ER0505-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.msard.2024.105914","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:27:35Z","timestamp":1727717255000},"page":"105914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quality of life in patients with myelin oligodendrocyte glycoprotein antibody associated disease compared to patients with AQP4-IgG positive neuromyelitis optica spectrum disorders: A Korean multicenter study"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9020-8558","authenticated-orcid":false,"given":"Hyun Ji","family":"Lyou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Lim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Nam","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-il","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Bin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seol-Hee","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Jo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunhee","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Myoung","family":"Seok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2024.105914_bib0001","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.4081\/ni.2017.7343","article-title":"Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates","volume":"9","author":"Alsaadi","year":"2017","journal-title":"Neurol. Int."},{"issue":"12","key":"10.1016\/j.msard.2024.105914_bib0002","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1007\/s00415-004-0567-0","article-title":"European validation of a standardized clinical description of multiple sclerosis","volume":"251","author":"Amato","year":"2004","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105914_bib0003","article-title":"Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders","volume":"4","author":"Asseyer","year":"2018","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"5","key":"10.1016\/j.msard.2024.105914_bib0004","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/ene.14729","article-title":"Pain, depression, and quality of life in adults with MOG-antibody-associated disease","volume":"28","author":"Asseyer","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105914_bib0005","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fneur.2020.00778","article-title":"Pain in NMOSD and MOGAD: a Systematic Literature Review of Pathophysiology, Symptoms, and Current Treatment Strategies","volume":"11","author":"Asseyer","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105914_bib0006","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000985","article-title":"Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: a Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients","volume":"8","author":"Ayzenberg","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.msard.2024.105914_bib0007","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2024.105914_bib0008","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.msard.2018.04.009","article-title":"Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: the first report from Iran","volume":"22","author":"Barzegar","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2024.105914_bib0009","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000580","article-title":"Neuromyelitis optica spectrum disorder Patient experience and quality of life","volume":"6","author":"Beekman","year":"2019","journal-title":"Neurology-Neuroimmunology & Neuroinflammation"},{"issue":"11","key":"10.1016\/j.msard.2024.105914_bib0010","doi-asserted-by":"crossref","first-page":"e49996","DOI":"10.1371\/journal.pone.0049996","article-title":"Poor sleep in patients with multiple sclerosis","volume":"7","author":"B\u00f8e Lunde","year":"2012","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.msard.2024.105914_bib0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index - a New Instrument for Psychiatric Practice and Research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.msard.2024.105914_bib0012","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S1041610206003619","article-title":"Assessment of the psychometric performance of the WHOQOL-BREF instrument in a sample of Brazilian older adults","volume":"19","author":"Chachamovich","year":"2007","journal-title":"Int. Psychogeriatr."},{"issue":"6","key":"10.1016\/j.msard.2024.105914_bib0013","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1212\/NXI.0000000000000286","article-title":"Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder","volume":"3","author":"Chavarro","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.msard.2024.105914_bib0014","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/jnnp-2020-324826","article-title":"Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS","volume":"92","author":"Duan","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.msard.2024.105914_bib0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2024.105914_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117546","article-title":"Patient-reported burden of symptoms in neuromyelitis optica: a secondary analysis on pain and quality of life","volume":"428","author":"Fujihara","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2024.105914_bib0017","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/anae.14444","article-title":"Changes in health-related quality of life after discharge from an intensive care unit: a systematic review","volume":"74","author":"Gerth","year":"2019","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.msard.2024.105914_bib0018","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MRR.0b013e32834ad479","article-title":"Quality of life in patients with multiple sclerosis: the impact of depression, fatigue, and disability","volume":"34","author":"Goksel Karatepe","year":"2011","journal-title":"Int. J. Rehabil. Res."},{"issue":"8","key":"10.1016\/j.msard.2024.105914_bib0019","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41583-018-0026-z","article-title":"Generation of circadian rhythms in the suprachiasmatic nucleus","volume":"19","author":"Hastings","year":"2018","journal-title":"Nature Reviews Neuroscience"},{"issue":"1","key":"10.1016\/j.msard.2024.105914_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11205-005-5552-1","article-title":"Interpreting the WHOQOL-Bref: preliminary population norms and effect sizes","volume":"77","author":"Hawthorne","year":"2006","journal-title":"Soc. Indic. Res."},{"issue":"3","key":"10.1016\/j.msard.2024.105914_bib0021","first-page":"454","article-title":"Costs and health-related quality of life in patients with neuromyelitis optica spectrum disorder and mog-antibody associated disease (chance(nmo)-study)","volume":"26","author":"Hummert","year":"2020","journal-title":"Multiple Sclerosis Journal"},{"issue":"11","key":"10.1016\/j.msard.2024.105914_bib0022","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.msard.2024.105914_bib0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3345\/cep.2019.01305","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options","volume":"64","author":"Lee","year":"2021","journal-title":"Clin. Exp. Pediatr."},{"key":"10.1016\/j.msard.2024.105914_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103825","article-title":"Is there a link between neuropathic pain and constipation in NMOSD and MOGAD? Results from an online patient survey and possible clinical implications","volume":"63","author":"Lotan","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2024.105914_bib0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7224\/1537-2073.2017-076","article-title":"Assessment of Patients with Neuromyelitis Optica Spectrum Disorder Using the EQ-5D","volume":"21","author":"Mealy","year":"2019","journal-title":"Int. J. MS. Care"},{"issue":"3","key":"10.1016\/j.msard.2024.105914_bib0026","first-page":"235","article-title":"The impact of pain, anxiety and depression on sleep quality in Chinese patients with neuromyelitis optica spectrum disorders","volume":"22","author":"Miao","year":"2017","journal-title":"Neurol. Asia"},{"issue":"6","key":"10.1016\/j.msard.2024.105914_bib0027","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1023\/A:1016351406336","article-title":"Development of the korean versions of WHO quality of life scale and WHOQOL-BREF","volume":"11","author":"Min","year":"2002","journal-title":"Quality of Life Research"},{"key":"10.1016\/j.msard.2024.105914_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577742","article-title":"Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): a prospective observational study and review of literature","volume":"361","author":"Nagireddy","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2024.105914_bib0029","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12883-021-02396-1","article-title":"Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review","volume":"21","author":"Oliva Ramirez","year":"2021","journal-title":"BMC. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2024.105914_bib0030","first-page":"1582","article-title":"Relationship between Sleep Quality and Quality of Life in Patients with Multiple Sclerosis","volume":"5","author":"Payam Sarraf","year":"2014","journal-title":"Int. J. Prev. Med."},{"issue":"7","key":"10.1016\/j.msard.2024.105914_bib0031","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s11136-020-02463-z","article-title":"The WHOQOL-BREF: a modern psychometric evaluation of its internal construct validity in people with multiple sclerosis","volume":"29","author":"Pomeroy","year":"2020","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.msard.2024.105914_bib0032","article-title":"Sleep disorders as a possible predisposing attack factor in neuromyelitis optica spectrum disorder (NMOSD): a case-control study","volume":"204","author":"Rabi","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2024.105914_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102718","article-title":"Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience","volume":"48","author":"Rempe","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105914_bib0034","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2017008","article-title":"The impact of disease characteristics on multiple sclerosis patients' quality of life","volume":"39","author":"Rezapour","year":"2017","journal-title":"Epidemiol. Health"},{"issue":"1","key":"10.1016\/j.msard.2024.105914_bib0035","first-page":"65","article-title":"The Effectiveness of Self-care Program on the Life Quality of Patients with Multiple Sclerosis in 2015","volume":"110","author":"Seifi","year":"2018","journal-title":"J. Natl. Med. Assoc."},{"issue":"5","key":"10.1016\/j.msard.2024.105914_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177230","article-title":"Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life","volume":"12","author":"Seok","year":"2017","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2024.105914_bib0037","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneuroim.2016.02.011","article-title":"Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression","volume":"293","author":"Shi","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"38","key":"10.1016\/j.msard.2024.105914_bib0038","doi-asserted-by":"crossref","first-page":"e17184","DOI":"10.1097\/MD.0000000000017184","article-title":"Comparison of psychiatric disturbances in patients with multiple sclerosis and neuromyelitis optica","volume":"98","author":"Shin","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.msard.2024.105914_bib0039","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1590\/S0034-8910.2014048004912","article-title":"Cut-off point for WHOQOL-bref as a measure of quality of life of older adults","volume":"48","author":"Silva","year":"2014","journal-title":"Revista De Saude Publica,"},{"issue":"9","key":"10.1016\/j.msard.2024.105914_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160261","article-title":"Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: an Italian Multi-Center Study Using the Beck Depression Inventory","volume":"11","author":"Solaro","year":"2016","journal-title":"PLoS. One"},{"issue":"11","key":"10.1016\/j.msard.2024.105914_bib0041","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1590\/S0004-282X2012001100011","article-title":"Spinal cord injury as a trigger to develop periodic leg movements during sleep: an evolutionary perspective","volume":"70","author":"Telles","year":"2012","journal-title":"Arquivos De Neuro-Psiquiatria,"},{"key":"10.1016\/j.msard.2024.105914_bib0042","article-title":"Clinical and Imaging Features of Patients With Encephalitic Symptoms and Myelin Oligodendrocyte Glycoprotein Antibodies","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2024.105914_bib0043","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"issue":"14","key":"10.1016\/j.msard.2024.105914_bib0044","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/09638280701476193","article-title":"Stability and relative validity of the Multiple Sclerosis Impact Profile (MSIP)","volume":"30","author":"Wynia","year":"2008","journal-title":"Disabil. Rehabil."},{"issue":"3","key":"10.1016\/j.msard.2024.105914_bib0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/acn3.51008","article-title":"Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies","volume":"7","author":"Yeo","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2024.105914_bib0046","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1177\/1352458514522103","article-title":"Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life","volume":"20","author":"Zhao","year":"2014","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T04:31:39Z","timestamp":1732336299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824004905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":46,"alternative-id":["S2211034824004905"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105914","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life in patients with myelin oligodendrocyte glycoprotein antibody associated disease compared to patients with AQP4-IgG positive neuromyelitis optica spectrum disorders: A Korean multicenter study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105914"}}